S1 Fig. Treespot TM interaction maps of AB8779 compared to R406 (Fostamatinib).
In vitro kinase profiling by DiscoverX. The result of a high-throughput system (KINOMEscan   TM ) for screening of both compounds against large numbers of human kinases (442 kinases) developed by Ambit Biosciences are visualised using a TREEspot TM interaction Maps. Kinases found to bind the compounds are marked with red circles, where larger circles indicate higheraffinity binding. The compounds were screened at the concentration of 1 µM, and results for primary screen binding interactions are reported as percent control (% Ctrl), where lower numbers indicate stronger hits. DMSO is used as a negative control (100% Ctrl) while a high affinity compound is used as a positive control (0% Ctrl). % Ctrl is calculated as follow:
The S-score of AB8779 tested in this assay is shown in S1 Table. These results clearly show that AB8779 is more specific than fostamatinib (R406).
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